a GDPR)
Key unknowns include: Long-term effects of repeated GH-axis stimulation Effects of sustained IGF-1 elevation Effects on glucose metabolism and insulin sensitivity Cardiovascular effects in higher-risk populations Immunogenicity after repeated exposure Differences between DAC and No DAC safety profiles Safety of non-pharmaceutical or poorly characterized peptide sources Why it matters: Short-term tolerability does not equal long-term safety
The decisive role of free fatty acids for protein conservation during fasting in humans with and without growth hormone
Thirty-three metabolites significantly influenced by SLE were put into the Metabolic Analyzer 5.0 platform to determine various potential metabolic pathways involved in the pathogenesis of SLE and immunomics
Optimal and safe upper limits of iodine intake for early pregnancy in iodine-sufficient regions: a cross-sectional study of 7,190 pregnant women in China
A method of preventing weakness in a patient with Parkinson's disease or of improving or restoring muscle strength of a patient with Parkinson's disease, comprising the step of administering to said patient an amount of one or more hepatocyte growth factor mimics sufficient to prevent, improve or restore to normal said muscle strength, said one or more hepatocyte growth factor mimics having a general structural formula 1 2 3 where R] is one of an N-acyl group, a substituted or unsubstiruted phenyl, a norleucine group, and an amino acid selected from tyrosine, phenylalanine, aspartic acid, arginine, isoleucine, serine, histidine, glycine, cysteine, methionine, tryptophan, lysine norvaline, ornithine, and s-benzyl cysteine
